ARCT CIK: 1768224

Arcturus Therapeutics Holdings Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
379
FY22:
403
FY23:
387
FY24:
306
FY25:
241
(positive)
Change from FY21 to FY25
millions USD
FY21:
13.9
FY22:
47.1
FY23:
42.8
FY24:
38.1
FY25:
29.7
Total assets
Change from FY21 to FY25
millions USD
FY21:
393
FY22:
450
FY23:
429
FY24:
344
FY25:
271

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
99.5
FY22:
127
FY23:
82.0
FY24:
65.5
FY25:
36.4
(negative)
Change from FY21 to FY25
millions USD
FY21:
65.1
FY22:
53.1
FY23:
68.9
FY24:
37.6
FY25:
20.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
228
FY22:
270
FY23:
279
FY24:
241
FY25:
214
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
393
FY22:
450
FY23:
429
FY24:
344
FY25:
271

All amounts in millions USD Data source:SEC EDGAR